OA10.03 YAP-NOTCH and STAT3 Signaling Rebound as a Compensatory Response to Gefitinib or Osimertinib Treatment in EGFR Mutant Lung Cancer
暂无分享，去创建一个
R. Rosell | A. Cardona | P. Ma | T. Bivona | Jie Yang | Xueting Cai | Chunping Hu | P. Cao | N. Karachaliou | A. Vergnenègre | A. Drozdowskyj | A. Verlicchi | C. Lazzari | I. Chaib | J. C. Servat | Á. Frías | C. C. Servat | M. A. M. Vila | J. Serrano